Fighting age-related nerve damage in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests if a treatment can help repair age-related damage to the protective coating around nerves in people with multiple sclerosis. It may help improve nerve function and slow disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of multiple sclerosis.
- You can walk 500 meters (about half a kilometer) without help.
- You have had MS for more than 10 years.
- You are between 50 and 70 years old.
- You speak and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a comprehensive rehabilitation program for people with multiple sclerosis that includes physiotherapy and regular check-ups with MRI scans. It aims to see if the program can help improve mobility and overall function.
This study tests if a non-invasive treatment called remote ischemic conditioning can help people with primary progressive multiple sclerosis. You wear a blood pressure cuff on your arm that briefly stops blood flow and then releases it, repeated for several cycles. The goal is to see if this improves walking and other functions.
This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.
This study uses powerful MRI scans to understand how the brain ages and why some people stay healthy while others develop neurological diseases like multiple sclerosis or Alzheimer's. It compares healthy volunteers to people with certain conditions, and all participants get a detailed brain MRI.
This trial tests an experimental drug called ifenprodil to see if it can repair the protective coating (myelin) around nerves in the eye and brain for people with relapsing-remitting MS. You may join if you have a delayed visual signal in one eye and enough remaining nerve fibers to potentially rebuild myelin.
This trial uses brain stimulation and MRI to study how the brain controls muscle movement in people with relapsing-remitting MS. Researchers want to understand changes in brain 'inhibition' (a natural stopping signal) that might affect walking or thinking.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.